SURDIAL™ DX Hemodialysis System
End-stage renal disease (ESRD)
CommercialActive
Key Facts
About Nipro Medical
Nipro Medical Corporation, founded in 1984 and headquartered in Clearwater, Florida, is a commercial-stage medical device company operating in the renal care and vascular intervention markets. It is a key regional arm of the Japanese Nipro Group, leveraging global R&D to serve the North American market with products like the SURDIAL™ DX hemodialysis system and the Makoto™ intravascular imaging platform. The company is revenue-generating, supported by a broad portfolio of commercial products and a recent manufacturing expansion in Greenville, NC, indicating a commitment to growth and operational scale in the region.
View full company profileTherapeutic Areas
Other End-stage renal disease (ESRD) Drugs
| Drug | Company | Phase |
|---|---|---|
| Bioartificial Kidney | IVIVA Medical | Pre-clinical |
| Bioengineered Kidney Tissue Implant | Trestle Biotherapeutics | Pre-clinical |
| SCD-Adult | SeaStar Medical | Investigational |